Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
2.2.1 Carotegrast methyl Carotegrast methyl (AJM300) is an oral small-molecule 4-integrin antagonist tested in this multicenter, double-blind, placebo-controlled Phase III RCT (NCT03531892) involving 203 patients with moderately active UC who received either 960mg three times daily or placebo for 8 weeks (46)
Hyeon Gyeong Yoo
Keep scheduled followups (virtual or inperson) to monitor progress, manage side effects, and make dosing changes as needed
In the recently published SURMOUNT-5 trial, which evaluated weight reduction over 72 weeks with the maximum tolerated dose of tirzepatide (10 or 15 mg) vs semaglutide (1.7 or 2.4 mg) in adults with obesity without type 2 diabetes, tirzepatide showed superior efficacy
El tratamiento tuvo una duracin de 52 semanas y del total de 190 participantes, slo 165 (el 87% terminaron el estudio)
Adiponectin, TNF- and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis
